International Journal of Advances in Interdisciplinary Research encourages authors to make the data, code and materials that support their findings openly available, so that others can verify, reproduce and build on the work. Our policy follows the principle “as open as possible, as closed as necessary” and the FAIR principles (findable, accessible, interoperable, reusable).
Data availability statement (required)
Every research article must include a Data Availability Statement before the references, explaining where and how the data can be accessed. Examples:
- “The sequencing data are available in the NCBI Sequence Read Archive under BioProject PRJNA000000.”
- “The data supporting this study are openly available in Zenodo at https://doi.org/10.5281/zenodo.0000000.”
- “All data generated or analysed during this study are included in this article and its supplementary files.”
- “The data are available from the corresponding author on reasonable request, because they contain information that could compromise participant privacy.”
- “No new data were created or analysed in this study.” (for reviews and theoretical work)
Where to deposit data
- Community repositories are preferred where they exist: GenBank / ENA / DDBJ and SRA for sequences, PDB for structures, GEO or ArrayExpress for expression data, PRIDE for proteomics, MetaboLights for metabolomics, Dryad or Figshare for general data.
- General repositories such as Zenodo, Figshare, Mendeley Data or an institutional repository, with a DOI.
- Code and software: GitHub or GitLab, archived with a DOI (for example through Zenodo), with a licence and version.
- Supplementary files submitted with the article are published alongside it.
Datasets and software should be cited in the reference list with their DOI or accession number.
Mandatory deposition
New nucleotide and protein sequences, macromolecular structures and microarray / high-throughput sequencing data must be deposited in the appropriate public repository, with accession numbers given in the manuscript, before the article is accepted.
Restrictions
Data may be restricted for legitimate reasons — participant privacy and consent, ethical or legal restrictions, biosafety, or third-party ownership. In these cases, the statement should explain the restriction and how qualified researchers can request access. Human participant data must be anonymised and shared only in line with the consent given and the approval of the ethics committee.
During peer review
Editors and reviewers may ask to see the underlying data or code to assess a manuscript. Data shared for review is treated as confidential. Refusal to provide data that is essential to evaluate the conclusions may lead to rejection.
After publication
If readers cannot obtain data described as “available on request”, they may contact the editorial office. Persistent failure to share data, or evidence that data have been fabricated or manipulated, is handled under our Complaints and Corrections & Retractions policies.